Ophthotech Announces Results from Phase 2a Safety Trial of Zimura® in Combination with Lucentis® in Wet Age-Related Macular Degeneration
NEW YORK--(BUSINESS WIRE)--Ophthotech announced the results from its Phase 2a safety trial of Zimura® in patients with wet age-related macular degeneration (AMD).